What’s holding pharma back from the next antibiotic breakthrough?
JANICE CARR/CDC VIA AP
Companies aiming to develop new antibiotics face hurdles such as small target populations and stewarship committees. Push and pull incentives can help them.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario